M. Oğuz

Association of echocardiographic parameters with chest computed tomography score in patients with COVID-19 disease

F. Şaylık, T. Akbulut, M. Oğuz, 2021, Advances in Medical Sciences.

Evaluation of Demographic, Clinical, and Etiological Data of Patients Admitted to Cardiology Clinics And Diagnosed with Left Ventricular Hypertrophy (LVH) on Electrocardiography And/Or Echocardiography: LVH-TR

O. Akhan, E. Akşit, Murat Bayrak, 2022 .

Fragmented QRS in inferior leads is associated with non-alcholic fatty liver disease, body-mass index, and interventricular septum thickness in young men

Cihan Şengül, T. Akbulut, M. Oğuz, 2022, Anatolian journal of cardiology.

Glycogen storage disease type 1b: an early onset severe phenotype associated with a novel mutation (IVS4) in the glucose 6-phosphate translocase (SLC37A4) gene in a Turkish patient.

G. Yılmaz, C. Aytekin, M. Oğuz, 2014, Genetic counseling.

Prevalence of Fabry Disease in patients with left ventricular hypertrophy in Turkey: Multicenter study (LVH-TR subgroup analysis)

E. Akşit, Murat Bayrak, M. Zoghi, 2023, The International Journal of Cardiovascular Imaging.

Association of Coronary Artery Severity and Late In-Stent Restenosis: An Angiographic Imaging Study

F. Şaylık, T. Akbulut, M. Oğuz, 2023, Angiology.

Comparison of Framingham, SCORE, PROCAM and TEKHARF Risk Scores for Prediction of 10 Year Cardiovascular Disease Risk in Patients with Essential Hypertension

D. Ural, F. Şaylık, T. Akbulut, 2022, Kocaeli Medical Journal.